{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:19:20Z","timestamp":1793477960891,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National key research & development plan of China, Project of prevention and treatment for common diseases","award":["2022YFC2505306"],"award-info":[{"award-number":["2022YFC2505306"]}]},{"name":"National key research & development plan of China, Project of prevention and treatment for common diseases","award":["2022YFC2505302"],"award-info":[{"award-number":["2022YFC2505302"]}]},{"name":"National key research & development plan of China, Project of prevention and treatment for common diseases","award":["2022YFC2505301"],"award-info":[{"award-number":["2022YFC2505301"]}]},{"name":"Chongqing Outstanding Youth Science Fund project","award":["CSTB2023NSCQ-JQX0028"],"award-info":[{"award-number":["CSTB2023NSCQ-JQX0028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04326-4","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T05:08:39Z","timestamp":1751692119000},"page":"952-960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of different criteria of captopril challenge test for the diagnosis of primary aldosteronism"],"prefix":"10.1007","volume":"90","author":[{"given":"Qiang","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shili","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5008-1983","authenticated-orcid":false,"given":"Yifan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-4779","authenticated-orcid":false,"given":"Shumin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5478-5582","authenticated-orcid":false,"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Chongqing Primary Aldosteronism Study (CONPASS) Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangla","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"issue":"14","key":"4326_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"S. Monticone, J. Burrello, D. Tizzani, C. Bertello, A. Viola, F. Buffolo et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J. Am. Coll. Cardiol. 69(14), 1811\u20131820 (2017). https:\/\/doi.org\/10.1016\/j.jacc.2017.01.052","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"4326_CR2","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1210\/jc.2016-1472","volume":"101","author":"SC K\u00e4yser","year":"2016","unstructured":"S.C. K\u00e4yser, T. Dekkers, H.J. Groenewoud, G.J. van der Wilt, J. Carel Bakx, M.C. van der Wel et al. Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis. J. Clin. Endocrinol. Metab. 101(7), 2826\u20132835 (2016). https:\/\/doi.org\/10.1210\/jc.2016-1472","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"16","key":"4326_CR3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","volume":"75","author":"Z Xu","year":"2020","unstructured":"Z. Xu, J. Yang, J. Hu, Y. Song, W. He, T. Luo et al. Primary aldosteronism in patients in china with recently detected hypertension. J. Am. Coll. Cardiol. 75(16), 1913\u20131922 (2020). https:\/\/doi.org\/10.1016\/j.jacc.2020.02.052","journal-title":"J. Am. Coll. Cardiol."},{"key":"4326_CR4","doi-asserted-by":"publisher","first-page":"e065250","DOI":"10.1136\/bmj-2021-065250","volume":"377","author":"KW Choy","year":"2022","unstructured":"K.W. Choy, P.J. Fuller, G. Russell, Q. Li, M. Leenaerts, J. Yang, Primary aldosteronism. BMJ 377, e065250 (2022). https:\/\/doi.org\/10.1136\/bmj-2021-065250","journal-title":"BMJ"},{"issue":"8","key":"4326_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"P. Milliez, X. Girerd, P.F. Plouin, J. Blacher, M.E. Safar, J.J. Mourad, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 45(8), 1243\u20131248 (2005). https:\/\/doi.org\/10.1016\/j.jacc.2005.01.015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"4326_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"S. Monticone, F. D\u2019Ascenzo, C. Moretti, T.A. Williams, F. Veglio, F. Gaita et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6(1), 41\u201350 (2018). https:\/\/doi.org\/10.1016\/s2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"12","key":"4326_CR7","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1161\/hypertensionaha.123.21895","volume":"80","author":"E Gkaniatsa","year":"2023","unstructured":"E. Gkaniatsa, T. Zverkova Sandstr\u00f6m, A. Rosengren, P. Trimpou, D.S. Olsson, M. Lind et al. Mortality in patients with primary aldosteronism: a swedish nationwide study. Hypertension 80(12), 2601\u20132610 (2023). https:\/\/doi.org\/10.1161\/hypertensionaha.123.21895","journal-title":"Hypertension"},{"issue":"12","key":"4326_CR8","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"P. Mulatero, S. Monticone, C. Bertello, A. Viola, D. Tizzani, A. Iannaccone et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 98(12), 4826\u20134833 (2013). https:\/\/doi.org\/10.1210\/jc.2013-2805","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4326_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/hypertensionaha.113.01060","volume":"62","author":"S Savard","year":"2013","unstructured":"S. Savard, L. Amar, P.F. Plouin, O. Steichen, Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 62(2), 331\u2013336 (2013). https:\/\/doi.org\/10.1161\/hypertensionaha.113.01060","journal-title":"Hypertension"},{"issue":"5","key":"4326_CR10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889\u20131916 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"4326_CR11","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/hjh.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"P. Mulatero, S. Monticone, J. Deinum, L. Amar, A. Prejbisz, M.C. Zennaro et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the european society of hypertension. J. Hypertens. 38(10), 1919\u20131928 (2020). https:\/\/doi.org\/10.1097\/hjh.0000000000002510","journal-title":"J. Hypertens."},{"issue":"10","key":"4326_CR12","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1097\/hjh.0000000000002520","volume":"38","author":"P Mulatero","year":"2020","unstructured":"P. Mulatero, L.A. Sechi, T.A. Williams, J.W.M. Lenders, M. Reincke, F. Satoh et al. Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the working group on endocrine hypertension of the european society of hypertension. J. Hypertens. 38(10), 1929\u20131936 (2020). https:\/\/doi.org\/10.1097\/hjh.0000000000002520","journal-title":"J. Hypertens."},{"issue":"1","key":"4326_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1161\/hypertensionaha.117.10197","volume":"71","author":"Y Song","year":"2018","unstructured":"Y. Song, S. Yang, W. He, J. Hu, Q. Cheng, Y. Wang et al. Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study. Hypertension 71(1), 118\u2013124 (2018). https:\/\/doi.org\/10.1161\/hypertensionaha.117.10197","journal-title":"Hypertension"},{"issue":"3","key":"4326_CR14","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s12020-024-03885-2","volume":"85","author":"H Shen","year":"2024","unstructured":"H. Shen, W. Luo, J. Hu, J. Yang, Y. Song, X. Chen et al. Comparison of four confirmatory tests for the diagnosis of primary aldosteronism: bayesian analysis in the absence of a gold standard. Endocrine 85(3), 1417\u20131424 (2024). https:\/\/doi.org\/10.1007\/s12020-024-03885-2","journal-title":"Endocrine"},{"issue":"3","key":"4326_CR15","doi-asserted-by":"publisher","first-page":"147032031987089","DOI":"10.1177\/1470320319870891","volume":"20","author":"S Kidoguchi","year":"2019","unstructured":"S. Kidoguchi, N. Sugano, N. Hayashi-Ishikawa, N. Morisawa, G. Tokudome, T. Yokoo, The characteristics of captopril challenge test-positive patients using various criteria. J. Renin Angiotensin Aldosterone Syst. 20(3), 1470320319870891 (2019). https:\/\/doi.org\/10.1177\/1470320319870891","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"1","key":"4326_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0390-3","volume":"19","author":"KY Zhu","year":"2019","unstructured":"K.Y. Zhu, Y. Zhang, W.J. Zhang, H.Y. Li, W.H. Feng, D.L. Zhu et al. The captopril challenge test for diagnosing primary aldosteronism in a Chinese population. BMC Endocr. Disord. 19(1), 65 (2019). https:\/\/doi.org\/10.1186\/s12902-019-0390-3","journal-title":"BMC Endocr. Disord."},{"key":"4326_CR17","doi-asserted-by":"publisher","first-page":"689618","DOI":"10.3389\/fendo.2021.689618","volume":"12","author":"Q Xiang","year":"2021","unstructured":"Q. Xiang, T. Chen, K. Yu, Y. Li, Q. Li, H. Tian et al. The value of different single or combined indexes of the captopril challenge test in the diagnosis of primary aldosteronism. Front. Endocrinol. 12, 689618 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.689618","journal-title":"Front. Endocrinol."},{"issue":"2","key":"4326_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3803\/EnM.2016.31.2.277","volume":"31","author":"JH Kim","year":"2016","unstructured":"J.H. Kim, K.S. Park, A.R. Hong, C.S. Shin, S.Y. Kim, S.W. Kim, Diagnostic role of captopril challenge test in Korean subjects with high aldosterone-to-renin ratios. Endocrinol. Metab. 31(2), 277\u2013283 (2016). https:\/\/doi.org\/10.3803\/EnM.2016.31.2.277","journal-title":"Endocrinol. Metab."},{"issue":"4","key":"4326_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","volume":"69","author":"M Naruse","year":"2022","unstructured":"M. Naruse, T. Katabami, H. Shibata, M. Sone, K. Takahashi, A. Tanabe et al. Japan endocrine society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr. J. 69(4), 327\u2013359 (2022). https:\/\/doi.org\/10.1507\/endocrj.EJ21-0508","journal-title":"Endocr. J."},{"issue":"9","key":"4326_CR20","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1097\/hjh.0000000000003197","volume":"40","author":"Y Song","year":"2022","unstructured":"Y. Song, J. Yang, H. Shen, E. Ng, P.J. Fuller, Z. Feng et al. Development and validation of model for sparing adrenal venous sampling in diagnosing unilateral primary aldosteronism. J. Hypertens. 40(9), 1692\u20131701 (2022). https:\/\/doi.org\/10.1097\/hjh.0000000000003197","journal-title":"J. Hypertens."},{"issue":"1","key":"4326_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12020-023-03520-6","volume":"83","author":"X Li","year":"2024","unstructured":"X. Li, J. Liang, J. Hu, L. Ma, J. Yang, A. Zhang et al. Screening for primary aldosteronism on and off interfering medications. Endocrine 83(1), 178\u2013187 (2024). https:\/\/doi.org\/10.1007\/s12020-023-03520-6","journal-title":"Endocrine"},{"issue":"7","key":"4326_CR22","doi-asserted-by":"publisher","first-page":"dgaa282","DOI":"10.1210\/clinem\/dgaa282","volume":"105","author":"K Wang","year":"2020","unstructured":"K. Wang, J. Hu, J. Yang, Y. Song, P.J. Fuller, H. Hashimura et al. Development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism. J. Clin. Endocrinol. Metab. 105(7), dgaa282 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa282","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4326_CR23","doi-asserted-by":"publisher","first-page":"8647026","DOI":"10.1155\/2018\/8647026","volume":"2018","author":"L Ma","year":"2018","unstructured":"L. Ma, Y. Song, M. Mei, W. He, J. Hu, Q. Cheng et al. Age-related cutoffs of plasma aldosterone\/renin concentration for primary aldosteronism screening. Int. J. Endocrinol. 2018, 8647026 (2018). https:\/\/doi.org\/10.1155\/2018\/8647026","journal-title":"Int. J. Endocrinol."},{"issue":"4","key":"4326_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.eprac.2020.10.016","volume":"27","author":"B Liu","year":"2021","unstructured":"B. Liu, J. Hu, Y. Song, W. He, Q. Cheng, Z. Wang et al. Seated saline suppression test is comparable with captopril challenge test for the diagnosis of primary aldosteronism: a prospective study. Endocr. Pract. 27(4), 326\u2013333 (2021). https:\/\/doi.org\/10.1016\/j.eprac.2020.10.016","journal-title":"Endocr. Pract."},{"issue":"3","key":"4326_CR25","doi-asserted-by":"publisher","first-page":"dgz150","DOI":"10.1210\/clinem\/dgz150","volume":"105","author":"M Thuzar","year":"2020","unstructured":"M. Thuzar, K. Young, A.H. Ahmed, G. Ward, M. Wolley, Z. Guo et al. Diagnosis of primary aldosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS\/MS. J. Clin. Endocrinol. Metab. 105(3), dgz150 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgz150","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"4326_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/s2213-8587(14)70069-5","volume":"3","author":"S Monticone","year":"2015","unstructured":"S. Monticone, A. Viola, D. Rossato, F. Veglio, M. Reincke, C. Gomez-Sanchez et al. Adrenal vein sampling in primary aldosteronism: towards a standardised protocol. Lancet Diabetes Endocrinol. 3(4), 296\u2013303 (2015). https:\/\/doi.org\/10.1016\/s2213-8587(14)70069-5","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"4326_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/hypertensionaha.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"G.P. Rossi, R.J. Auchus, M. Brown, J.W. Lenders, M. Naruse, P.F. Plouin et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 63(1), 151\u2013160 (2014). https:\/\/doi.org\/10.1161\/hypertensionaha.113.02097","journal-title":"Hypertension"},{"issue":"10","key":"4326_CR28","doi-asserted-by":"publisher","first-page":"e2338209","DOI":"10.1001\/jamanetworkopen.2023.38209","volume":"6","author":"S Yang","year":"2023","unstructured":"S. Yang, Z. Du, X. Zhang, Q. Zhen, X. Shu, J. Yang et al. Corticotropin stimulation in adrenal venous sampling for patients with primary aldosteronism: the ADOPA randomized clinical trial. JAMA Netw. Open. 6(10), e2338209 (2023). https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.38209","journal-title":"JAMA Netw. Open."},{"issue":"9","key":"4326_CR29","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"T.A. Williams, J.W.M. Lenders, P. Mulatero, J. Burrello, M. Rottenkolber, C. Adolf et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 5(9), 689\u2013699 (2017). https:\/\/doi.org\/10.1016\/s2213-8587(17)30135-3","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"4326_CR30","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1210\/jcem-57-5-892","volume":"57","author":"DF Lyons","year":"1983","unstructured":"D.F. Lyons, D.C. Kem, R.D. Brown, C.S. Hanson, M.L. Carollo, Single dose captopril as a diagnostic test for primary aldosteronism. J. Clin. Endocrinol. Metab. 57(5), 892\u2013896 (1983). https:\/\/doi.org\/10.1210\/jcem-57-5-892","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4326_CR31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/1470320310390405","volume":"12","author":"C Westerdahl","year":"2011","unstructured":"C. Westerdahl, A. Bergenfelz, A. Isaksson, S. Valdemarsson, Captopril suppression: limitations for confirmation of primary aldosteronism. J. Renin Angiotensin Aldosterone Syst. 12(3), 326\u2013332 (2011). https:\/\/doi.org\/10.1177\/1470320310390405","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"4326_CR32","doi-asserted-by":"publisher","first-page":"1183161","DOI":"10.3389\/fendo.2023.1183161","volume":"14","author":"X Liu","year":"2023","unstructured":"X. Liu, C. Guo, J. Bian, S. Hao, Y. Lou, H. Zhang et al. Captopril challenge test in the diagnosis of primary aldosteronism: consistency between 1- and 2- h sampling. Front. Endocrinol. 14, 1183161 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1183161","journal-title":"Front. Endocrinol."},{"issue":"2","key":"4326_CR33","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1161\/hypertensionaha.107.093468","volume":"50","author":"P Mulatero","year":"2007","unstructured":"P. Mulatero, C. Bertello, C. Garrone, D. Rossato, G. Mengozzi, A. Verhovez et al. Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension 50(2), e26\u2013e27 (2007). https:\/\/doi.org\/10.1161\/hypertensionaha.107.093468","journal-title":"Hypertension"},{"issue":"6","key":"4326_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1055\/s-0029-1246186","volume":"42","author":"P Mulatero","year":"2010","unstructured":"P. Mulatero, S. Monticone, C. Bertello, G. Mengozzi, D. Tizzani, A. Iannaccone et al. Confirmatory tests in the diagnosis of primary aldosteronism. Horm. Metab. Res. 42(6), 406\u2013410 (2010). https:\/\/doi.org\/10.1055\/s-0029-1246186","journal-title":"Horm. Metab. Res."},{"key":"4326_CR35","doi-asserted-by":"publisher","first-page":"1343704","DOI":"10.3389\/fendo.2024.1343704","volume":"15","author":"K Sun","year":"2024","unstructured":"K. Sun, M. Gong, Y. Yu, M. Yang, Y. Zhang, Y. Jiang et al. Comparison of saline infusion test and captopril challenge test in the diagnosis of Chinese with primary aldosteronism in different age groups. Front. Endocrinol. 15, 1343704 (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1343704","journal-title":"Front. Endocrinol."},{"issue":"3","key":"4326_CR36","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1210\/jc.2017-01530","volume":"103","author":"X Meng","year":"2018","unstructured":"X. Meng, Y. Li, X. Wang, J. Li, Y. Liu, Y. Yu, Evaluation of the saline infusion test and the captopril challenge test in Chinese patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 103(3), 853\u2013860 (2018). https:\/\/doi.org\/10.1210\/jc.2017-01530","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4326_CR37","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/cen.13943","volume":"90","author":"S Wu","year":"2019","unstructured":"S. Wu, J. Yang, J. Hu, Y. Song, W. He, S. Yang et al. Confirmatory tests for the diagnosis of primary aldosteronism: a systematic review and meta-analysis. Clin. Endocrinol. 90(5), 641\u2013648 (2019). https:\/\/doi.org\/10.1111\/cen.13943","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"4326_CR38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/hypertensionaha.107.091827","volume":"50","author":"GP Rossi","year":"2007","unstructured":"G.P. Rossi, A. Belfiore, G. Bernini, G. Desideri, B. Fabris, C. Ferri et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50(2), 424\u2013431 (2007). https:\/\/doi.org\/10.1161\/hypertensionaha.107.091827","journal-title":"Hypertension"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04326-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04326-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04326-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:06:39Z","timestamp":1761735999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04326-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4326"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04326-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}